Homoeopathic Treatment of Young Females with Subclinical Hypothyroidism: A Prospective Observational Study

Abstract

Introduction Subclinical hypothyroidism (SCH) is defined as elevated levels of serum thyroid-stimulating hormone (TSH) (TSH: 5–20 μIU/mL; normal range: 0.15–3.5 μIU/mL) with normal serum levels of free thyroid hormones mainly free T4 (0.89–1.76 ng/dL). SCH does not affect the development process very much and hence there are no universally accepted recommendations for its treatment but it is important to have optimal thyroid function for normal growth and development in children; it may progress to overt hypothyroidism and other health issues. So, its diagnosis in early stage of life and hence its treatment will definitely benefit the growing children.

Objective The objective of this study is to review the role of homoeopathy in SCH in younger aged females.

Method Total 212 cases were screened, 54 diagnosed cases of SCH were enrolled on the basis of inclusion criteria and 4 cases dropped out from the study. Total 50 cases were given individualised homoeopathic medicines based on repertorisation of totality of symptoms and in consultation with Materia Medica.

Result Results showed significant difference after comparing pre- and post-treatment values using paired t-test; the difference in mean values of Serum TSH values was found to be statistically significant (p-value < 0.00001). At baseline, the mean TSH level was 7.158 μIU/mL which decreased to 4.368 μIU/mL (p < 0.00001).

Conclusion This study indicates the positive role of homoeopathic therapy in the management of SCH. Such study with bigger sample size through randomised controlled trial is needed for further validation.

Keywords

homoeopathy - subclinical hypothyroidism - TSH - thyroid hormones

Declaration of Patient Consent

The authors certify that they have obtained consent forms from all the patients.

Financial Support and Sponsorship

Nil.

Publication History

Article published online:
29 December 2022

• References

• 1 Canaris GJ, Manowitz NR, Mayor G, Ridgway EC. The Colorado thyroid disease prevalence study. Arch Intern Med 2000; 160 (04) 526-534
• 2 Vanderpump MP, Tunbridge WM, French JM. et al. The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham Survey. Clin Endocrinol (Oxf) 1995; 43 (01) 55-68
• 3 Surks MI, Ortiz E, Daniels GH. et al. Subclinical thyroid disease: scientific review and guidelines for diagnosis and management. JAMA 2004; 291 (02) 228-238
• 4 Biondi B, Cooper DS. The clinical significance of subclinical thyroid dysfunction. Endocr Rev 2008; 29 (01) 76-131
• 5 Somwaru LL, Rariy CM, Arnold AM, Cappola AR. The natural history of subclinical hypothyroidism in the elderly: the cardiovascular health study. J Clin Endocrinol Metab 2012; 97 (06) 1962-1969
• 6 Rugge B, Balshem H, Sehgal R. et al. Screening and Treatment of Subclinical Hypothyroidism or Hyperthyroidism [Internet]. Rockville (MD): Agency for Healthcare Research and Quality (US); 2011
• 7 Sutar SB, Mishra S. Pulmonary function test in patients with subclinical hypothyroidism: a study from eastern India. Indian J Appl Res 2019; 9 (09) 26-27
• 8 Garber JR, Cobin RH, Gharib H. et al; American Association of Clinical Endocrinologists and American Thyroid Association Taskforce on Hypothyroidism in Adults. Clinical practice guidelines for hypothyroidism in adults: cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association. Endocr Pract 2012; 18 (06) 988-1028
• 9 Deshmukh V, Behl A, Iyer V, Joshi H, Dholye JP, Varthakavi PK. Prevalence, clinical and biochemical profile of subclinical hypothyroidism in normal population in Mumbai. Indian J Endocrinol Metab 2013; 17 (03) 454-459
• 10 Hahnemann S. Organon of Medicine. 5th & 6th editions. New Delhi: B Jain Publishers (P) Ltd.; 1994
• 11 Meier C, Staub JJ, Roth CB. et al. TSH controlled L-thyroxine therapy reduces cholesterol levels and clinical symptoms in subclinical hypothyroidism: Adobule blind, placebo controlled trial (Basel thyroid study). J Clin Endocrinol Metab 2001; 86: 4860-4866
• 12 Cooper DS. Clinical practice. Subclinical hypothyroidism. N Engl J Med 2001; 345 (04) 260-265
• 13 Schoenfeld PS, Myers JW, Myers L, LaRocque JC. Suppression of cell-mediated immunity in hypothyroidism. South Med J 1995; 88 (03) 347-349
• 14 Bianchi GP, Zaccheroni V, Solaroli E. et al. Health-related quality of life in patients with thyroid disorders. Qual Life Res 2004; 13 (01) 45-54
• 15 Carani C, Isidori AM, Granata A. et al. Multicenter study on the prevalence of sexual symptoms in male hypo- and hyperthyroid patients. J Clin Endocrinol Metab 2005; 90 (12) 6472-6479
• 16 Radetti G, Maselli M, Buzi F. et al. The natural history of the normal/mild elevated TSH serum levels in children and adolescents with Hashimoto's thyroiditis and isolated hyperthyrotropinaemia: a 3-year follow-up. Clin Endocrinol (Oxf) 2012; 76 (03) 394-398
• 17 Chauhan VK, Manchanda RK, Narang A. et al. Efficacy of homeopathic intervention in subclinical hypothyroidism with or without autoimmune thyroiditis in children: an exploratory randomized control study. Homeopathy 2014; 103 (04) 224-231
• 18 Srivastava NK. Evidence based clinical study on hypothyroidism. Clinical Experimental Homoeopathy 2019; 6 (01) 3-11